Home » Reports » Oxford BioMedica plc 50.6% Potential Upside Indicated by Liberum Capital

Oxford BioMedica plc 50.6% Potential Upside Indicated by Liberum Capital

Oxford BioMedica plc using EPIC/TICKER code (LON:OXB) has had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘BUY’ today by analysts at Liberum Capital. Oxford BioMedica plc are listed in the Health Care sector within UK Main Market. Liberum Capital have set a target price of 1090 GBX on its stock. This would imply the analyst believes there is now a potential upside of 50.6% from today’s opening price of 724 GBX. Over the last 30 and 90 trading days the company share price has increased 186 points and increased 94 points respectively. The 1 year high share price is 794.88 GBX while the year low stock price is currently 356.73 GBX.

Oxford BioMedica plc has a 50 day moving average of 623.49 GBX and the 200 Day Moving Average price is recorded at 623.28. There are currently 250,000,000 shares in issue with the average daily volume traded being 214,304. Market capitalisation for LON:OXB is £560,657,708 GBP.

Join us on our new LinkedIn page

Follow us on LinkedIn